Industry / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Reducing State Funding For The Chronically Ill
June 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
The French government's plans to reduce reimbursement levels for pharmaceuticals used by the chronically ill have been widely condemned by members of parliament (MPs). Parti Socialiste MP Jack Lang described the plans as 'unimaginable', while Union pour un Mouvement Populaire (UMP) MP Jérôme Chartier said that the proposals did not conform with French expectations of their national health service, and that it would be more sensible to review the classification of long-term illnesses. The plans are currently at an early stage of